Ramji Krishnan

Ramji has over 17 years of Product Development and Life Cycle Management experience across Analytical Sciences, Process Development, Commercial Process Support and Manufacturing Sciences. At both Celgene and BMS, he has contributed and led CMC teams through successful license applications and post approval activities for numerous complex biologics and cell therapy assets across a range of serious diseases: Orencia and Nulojix in immunology/transplant, Myalept in metabolics, Yervoy, Opdivo, Liso-cel and Reblozyl in Oncology/Immuno-Oncology. He has also led inspection readiness teams at commercial manufacturing sites towards successful outcomes (PLI/PAI) during interactions with multiple health agencies as FDA/Health Canada and ANVISA. Ramji received a Ph.D from the University of Connecticut and served as a post-doctoral fellow at Johns Hopkins University and Memorial Sloan Kettering Cancer Center.